Polling by the site FiveThirtyEight on 3 November had current Vice President Kamala Harris with a less than 1% lead over ...

Disc Medicine has announced a US Food and Drug Administration (FDA) agreement on the regulatory path for its investigational ...

The US FDA has granted fast track designation to FELIQS’ lead product FLQ-101 for preventing retinopathy of prematurity (ROP) ...

Researchers from Northwestern and Case Western Reserve universities have developed a polymer therapeutic to treat ...

UK-based biopharmaceutical company Prokarium has received two Notices of Allowance from the US Patent and Trademark Office.

Fiona Barry is the Editor-in-Chief of GlobalData PharmSource’s editorial content. She previously worked as an investigative ...

The US District Court upholds the FDA’s approval of Avadel’s Lumryz, dismissing Jazz’s challenge over market exclusivity for ...

Decentralized clinical trials are transforming medical research with more flexibility, improved patient engagement and faster ...

With the formation of a new strategic partnership, Dyno Therapeutics is responsible for the development of novel AAV capsids.

Biogen and Neomorph have entered a research partnership aimed at discovering and developing molecular glue degraders for the ...

The US FDA has approved Iterum Therapeutics' NDA for ORLYNVAH to treat uncomplicated urinary tract infections (uUTIs).

Green chemistry has the potential to revolutionise the pharmaceutical industry.